Clinical trial Recruiting at 1 site Interventional Ages Any age to 45 Women only

Freezing ovarian tissue to help women at risk of losing fertility

Official title: Cryopreservation of Ovarian Tissue for Potential In Vitro Maturation or Autologous Transplantation

Run by Weill Medical College of Cornell University · NCT01558544 · Data updated 2026-11-12

This study is testing if freezing ovarian tissue can help women at risk of losing their fertility due to cancer treatments or surgery have a chance to have children later on.

More Fertility Preservation trials

Quick facts

Study typeInterventional
AgesAny age to 45 Years
SexWomen only
Enrollment300 (estimated)
SponsorWeill Medical College of Cornell University
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (New York, New York)
StatusRecruiting
StartedApril 1997
Main results expectedOctober 31, 2029
Study endsOctober 31, 2029
Registry record updatedDecember 10, 2025
Trial IDNCT01558544 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premenopausal females aged 0-45 who are undergoing treatments likely to cause premature menopause or ovarian failure.

Probably not a fit

Patients who are already experiencing menopause or who have not received medical clearance for surgery will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the cryopreservation of ovarian tissue to preserve fertility in women who are at risk of premature ovarian failure due to cancer treatments or surgical interventions. Participants will undergo a thorough preoperative assessment, including imaging and blood tests, to evaluate ovarian function and reserve. Depending on the findings, one or both ovaries may be surgically removed for cryopreservation. The goal is to develop techniques that allow for the maturation of immature eggs, enabling women to conceive a genetically related child in the future.

Why it matters

Potential benefit: If successful, this approach could provide women at risk of infertility due to cancer treatments with the opportunity to conceive biologically related children.

How similar studies have gone: Other studies have shown promise in the field of ovarian tissue cryopreservation, indicating that this approach is gaining traction and may lead to successful outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Females 0-45 years of age who are premenopausal
* Treatment plan that will likely result in premature menopause or premature ovarian failure
* This includes patients receiving:
* Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
* Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
* Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
* Previous treatment for cancer is acceptable if patient still has ovarian function
* Patient is medically stable enough to undergo surgery (cleared for anesthesia)

Exclusion Criteria:

* Patients not meeting the above criteria
* Patients who have not received medical clearance from their physicians to undergo surgery
* Patients already experiencing menopause.

Where it's running

  • Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Glenn Schattman, MD — Weill Medical College of Cornell University
  • Study coordinator: Rodriq E. Stubbs, NP
  • Email: res2011@med.cornell.edu
  • Phone: 646-962-3276

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.